Pfizer High-Dose Lipitor Shows Coronary Disease Benefit-Study

MUNICH -(Dow Jones)- Intensive treatment with (PFE) cholesterol- lowering drug Lipitor significantly reduces the risk of major complications in severely ill patients with end-stage coronary disease, a new study presented Sunday has found. Coronary artery disease is a condition in which plaque builds up inside arteries. Patients with this conditions who have already suffered a heart attack patients reduced the... [read full story]